SPO Global Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SPOM research report →
About the company
Established in 2006 and headquartered in Jinan, China, Gerpang Healthcare Group operates as a bio-pharmaceutical enterprise. The company focuses on developing and marketing a diverse range of products, including genetically coated stents, vaccines for the Hepatitis B virus (HBV), monoclonal antibodies designed to detect male infertility, functional foods targeting cognitive disorders, and polypeptide-based probiotics.
- CEO
- Fengyou Lu
- IPO
- 1999
- Employees
- 7
- HQ
- Jinan, CN
Price Chart
- Market Cap
- $92.39K
- P/E
- 4.00
- P/S
- 0.38
- P/B
- -5.29
- EV/EBITDA
- -13.65
- Div Yield
- 0.00%
- Gross Margin
- 71.63%
- Op Margin
- -10.56%
- Net Margin
- -82.42%
- ROE
- 167.42%
- ROIC
- -16.50%
- Revenue
- $243.36K · -78.66%
- Net Income
- $-185,795 · 97.28%
- EPS
- $0.00 · 102.17%
- Op Income
- $-9,839
- FCF YoY
- -98.59%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 0.62
- Avg Volume
- 1.18M
Get TickerSpark's AI analysis on SPOM
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our SPOM coverage
Recent articles, reports, and earnings notes.
No research on SPOM yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SPOM report →Similar companies
Peers in the same neighborhood.